FDA orders andi-depressant labels be re-written

Antidepressant drug makers, including Eli Lilly, have been ordered to put new warnings on the most widely prescribed anti-depressants in the country. The Food and Drug Administration says labels need to be rewritten to state the use of these drugs lead to suicidal behavior in young adults.